LJI Wealth Management LLC Reduces Holdings in Intuitive Surgical, Inc. $ISRG

LJI Wealth Management LLC trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.5% in the 2nd quarter, Holdings Channel reports. The firm owned 1,122 shares of the medical equipment provider’s stock after selling 53 shares during the period. LJI Wealth Management LLC’s holdings in Intuitive Surgical were worth $610,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in ISRG. Nuveen LLC purchased a new stake in shares of Intuitive Surgical during the first quarter worth approximately $1,715,899,000. Goldman Sachs Group Inc. grew its holdings in Intuitive Surgical by 26.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider’s stock valued at $1,396,496,000 after buying an additional 584,375 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in Intuitive Surgical by 20.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider’s stock valued at $1,680,922,000 after buying an additional 566,979 shares in the last quarter. Wellington Management Group LLP grew its holdings in Intuitive Surgical by 15.0% in the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock valued at $1,732,975,000 after buying an additional 457,080 shares in the last quarter. Finally, Vanguard Group Inc. grew its holdings in Intuitive Surgical by 1.4% in the 1st quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock valued at $16,178,258,000 after buying an additional 453,335 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Trading Up 4.6%

ISRG opened at $551.30 on Friday. The stock’s 50-day moving average price is $456.77 and its 200 day moving average price is $496.40. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The firm has a market cap of $197.63 billion, a price-to-earnings ratio of 72.92, a PEG ratio of 5.53 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. During the same quarter in the prior year, the company earned $1.84 EPS. Intuitive Surgical’s revenue was up 22.9% on a year-over-year basis. On average, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. Truist Financial set a $620.00 target price on Intuitive Surgical and gave the company a “buy” rating in a report on Wednesday. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $685.00 price target on shares of Intuitive Surgical in a research note on Tuesday. Rothschild & Co Redburn upped their price target on Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a research note on Thursday. The Goldman Sachs Group decreased their price target on Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating on the stock in a research note on Wednesday, October 1st. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Eighteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $604.50.

Insider Activity

In other Intuitive Surgical news, Director Amy L. Ladd sold 336 shares of the stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total value of $157,956.96. Following the sale, the director owned 1,074 shares of the company’s stock, valued at $504,898.14. This trade represents a 23.83% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the sale, the insider directly owned 19,827 shares in the company, valued at $9,368,059.23. This represents a 59.69% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 40,724 shares of company stock worth $19,500,332. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.